Institution statistics

UNIVERSITA VITA SALUTE SAN RAFFAELE - Italy 

Ranking results:

Past rankings:
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:300-400
Total Project Funding:400-500
Total Project Funding per Partner:300-400
Total Number of Projects:64
Networking Rank (Reputation):600-700
Networking Rank (Reputation):600-700
Partner Constancy:46
Project Leadership Index:49
Diversity Index:47
2011
Criterium:Position:
Overall Score:700-800
Total Project Funding:800-900
Total Project Funding per Partner:400-500
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:300-400
2010
Criterium:Position:
Overall Score:700-800
Total Project Funding:500-600
Total Project Funding per Partner:400-500
Total Number of Projects:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:200-300
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding:400-500
Total Project Funding per Partner:500-600
Total Number of Projects:800-900
Networking Rank (Reputation):600-700
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:800-900
Total Project Funding:800-900
Total Project Funding per Partner:500-600
Total Number of Projects:500-600
Networking Rank (Reputation):800-900
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:800-900
Ranking timeline:

European project participation (2000-01-01 - 2017-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 46
As coordinator: 10
As participant: 33
Sole participant: 3
Coordinator / Participant Ratio: 0.3*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2016 180.277 19.361.446 1.804.405 1 2
2015 0 5.230.699 402.361 1
2013 5.999.997 14.126.427 2.953.004 1 3
2012 366.848 25.521.295 3.742.560 2 5
2011 929.224 15.486.322 2.446.064 1 2
2010 11.887.735 4.899.998 1.612.335 1 2
2009 27.685.681 0 1.279.862 3
2008 7.534.742 2.926.305 709.248 1 1
2007 0 5.575.339 578.488 3
2006 3.243.504 12.500.000 1.261.809 2 2
2005 0 13.970.000 1.021.609 3
2004 0 26.630.517 783.264 3
2001 0 2.873.533 478.922 2
2000 2.036.655 7.334.228 1.172.074 1 4
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE10
UNIVERSITY COLLEGE LONDON10
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR9
LUNDS UNIVERSITET7
UNIVERSITA DEGLI STUDI DI MILANO7
KAROLINSKA INSTITUTE6
KATHOLIEKE UNIVERSITEIT LEUVEN6
KING'S COLLEGE LONDON6
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE5
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
MEDIZINISCHE HOCHSCHULE HANNOVER5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD5
UNIVERSITAET ZUERICH5
UNIVERSITY OF HELSINKI5
COMMISSARIAT A L'ENERGIE ATOMIQUE4
CONSIGLIO NAZIONALE DELLE RICERCHE4
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4
MOLECULAR MEDICINE4
UNIVERSITA DEGLI STUDI DI TORINO4
WEIZMANN INSTITUTE OF SCIENCE4
DEUTSCHES KREBSFORSCHUNGSZENTRUM3
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
EUROPAEISCHES INSTITUT FUER FORSCHUNG UND ENTWICKLUNG VON TRANSPLANTATIONSSTRATEGIEN3
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
GATC BIOTECH3
GEORG SPEYER HAUS CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT3
LEIDEN UNIVERSITY MEDICAL CENTER3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
MAXPLANCKGESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV3
MEDIZINISCHE UNIVERSITAET WIEN3
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON3
THE HEBREW UNIVERSITY OF JERUSALEM3
THE UNIVERSITY OF LIVERPOOL3
UNIVERSITA DEGLI STUDI DI GENOVA3
UNIVERSITA DEGLI STUDI DI PADOVA3
UNIVERSITAETSKLINIKUM FREIBURG3
UPPSALA UNIVERSITET3
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER3
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ACIES SAS2
ALBERT LUDWIGS UNIVERSITAET FREIBURG2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
BIOXELL2
CENTRO DE INVESTIGACIONES ENERGETICAS MEDIOAMBIENTALES Y TECNOLOGICAS2
CF CONSULTING FINANZIAMENTI UNIONE EUROPEA2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH2
ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM2
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA2
GENETHON2
HOSPICES CANTONAUX CHUV2
INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU2
INSTITUT PASTEUR2
LUDWIG INSTITUTE FOR CANCER RESEARCH2
MAX DELBRUCK CENTER FOR MOLECULAR MEDICINE2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
MEDICAL RESEARCH COUNCIL2
MEDICAL UNIVERSITY OF GDANSK2
MILTENYI BIOTEC2
MRC NATIONAL INSTITUTE FOR MEDICAL RESEARCH2
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS2
POLITECNICO DI MILANO2
PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE2
REGION HOVEDSTADEN2
STATENS SERUM INSTITUT2
STOCKHOLMS UNIVERSITET2
TECHNISCHE UNIVERSITAET DRESDEN2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE2
THE JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE2
THE UNIVERSITY OF NOTTINGHAM2
UNIVERSIDAD AUTONOMA DE MADRID2
UNIVERSIDAD DE LA LAGUNA2
UNIVERSITA DEGLI STUDI DI BRESCIA2
UNIVERSITA DEGLI STUDI DI MILANO BICOCCA2
UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA2
UNIVERSITAET BASEL2
UNIVERSITAET ULM2
UNIVERSITAETSKLINIKUM BONN2
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ2
UNIVERSITE DE LIEGE2
UNIVERSITE FRANCOIS RABELAIS DE TOURS2
UNIVERSITEIT MAASTRICHT2
UNIVERSITY OF COPENHAGEN2
UNIVERSITY OF EAST ANGLIA2
UNIVERSITY OF GLASGOW2
UNIVERSITY OF MANCHESTER2
UNIVERSITY OF NEWCASTLE UPON TYNE2
UNIVERSITY OF SOUTHAMPTON2
VRIJE UNIVERSITEIT MEDICAL CENTER2
AALTO KORKEAKOULUSAATIO1
AARHUS UNIVERSITY HOSPITAL1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACTAR AB1
AFFIBODY AB1
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
AIBILII ASSOCIACAO DE APOIOAO INSTITUTO BIOMEDICO DE INVESTIGACAO DA LUZ E IMAGEM1
AKADEMIA MEDYCZNA W WARSZAWIE1
ALZHEIMER EUROPE1
ANIONA APS1
Constancy:

Total number of partners:683

Partner loyalty:
Frequent Partner: (> 2 projects): 172
Rare Partner: 511

Frequent / Rare Partner Ratio: 0.34

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES29
RTD HORIZONTAL TOPICS24
SOCIAL AND ECONOMIC CONCERNS6
INDUSTRY AND TECHNOLOGY3
PHYSICAL AND EXACT SCIENCES2
PROTECTING MAN AND HIS ENVIRON1
MEASUREMENTS AND STANDARDS1

Project overview:

Start dateProjectacronymrolefundingpartners
2016-04-15Investigation of the role of CYLD in Chronic Lymphocytic Leukaemia CIRCLEcoordinator180.2771
2016-04-01Enhanced Delivery Ecosystem for Neurosurgery in 2020 EDEN2020participant8.361.4468
2016-04-01Remote Assessment of Disease and Relapse in Central Nervous System Disorders RADAR-CNSparticipant11.000.00019
2015-03-01AEGLE (Ancient Greek: Αἴγλη) – An analytics framework for integrated and personalized healthcare services in Europe AEGLEparticipant5.230.69913
2013-10-01Treating stroke with Affibody molecules targeting the inflammatory mediator HMGB1 COUNTERSTROKEparticipant5.989.6316
2013-05-01Towards clinical translation of new gene targeting technologies for correcting inherited mutations and empowering adoptive immunotherapy of cancer SUPERSISTcoordinator5.999.9975
2013-03-01Development of an integrated SPECT/MRI system for enhanced stratification of brain tumour patients prior to patient-specific radio-chemo therapy and early assessment of treatment efficacy INSERTparticipant4.600.00010
2013-01-01Initial Training Network for Neurogical disorders orchestrated by cytoKines NEUROKINEparticipant3.536.79612
2012-12-01"Hydroxitirosol, a new generation of microbicides targeting HIV through antiviral and anti-inflammatory pathways" AIM-HIVparticipant1.827.0814
2012-04-16Quantifying transcription factor search mechanism by three-dimensional single molecule tracking SMT of TFscoordinator181.0842
2012-03-15"""Role of Nonlinear Dynamics of NF-kB in Inflammation""" NonLin-kBcoordinator185.7641
2012-03-01Imaging of Neuroinflammation in Neurodegenerative Diseases INMiNDparticipant11.998.47830
2012-03-01European Consortium for the Early Treatment of Diabetic Retinopathy EUROCONDORparticipant5.998.76218
2012-02-01In vivo dynamics of antibody responses to lymph-borne viruses IVM-VIRUS-nAbparticipant1.934.2001
2012-01-01EUropean TRanslational training for Autoimmunity & Immune manipulation Network EUTRAINparticipant3.762.77411
2011-12-01Targeting Brain Inflammation For Improved Functional Recovery in Acute Neurodegenerative Disorders TargetBraInparticipant11.989.16210
2011-11-01INternational VEnue for poSTgraduate education INVESTcoordinator929.2241
2011-10-01Atopic diseases in changing climate, land use and air quality ATOPICAparticipant3.497.16011
2010-11-01Advanced Cell-based Therapies for the treatment of Primary ImmunoDeficiency CELL-PIDcoordinator11.887.73520
2010-09-01Diagnostic Enhancement of Confidence by an International Distributed Environment DECIDEparticipant2.399.99813
2010-05-01Towards Safe and Effective Hematopoietic Stem Cell Gene Therapy: Targeting Integration to Genomic Safe Harbors and Exploiting Endogenous microRNA to Regulate Transgene Expression TARGETINGGENETHERAPYparticipant2.500.0003
2009-02-01Novel approaches to bacterial target identification, validation and inhibition NABATIVIcoordinator5.506.00010
2009-01-01Pan-European network for the study and clinical management of drug resistant tuberculosis TB PAN-NETcoordinator10.998.27032
2009-01-01Persisting Transgenesis PERSISTcoordinator11.181.41129
2008-12-01Genomic determinants of inflammation: from physical measurements to system perturbation and mathematical modeling MODEL-INparticipant2.926.30511
2008-02-01Next generation HIV-1 immunogens inducing broadly reactive neutralising antibodies NGINcoordinator7.534.74217
2007-03-15Measuring and modelling relativistic-like effects in brain and NCSs MEMORYparticipant1.281.0005
2007-02-01Measuring the impossible network MINETparticipant1.498.33922
2007-01-01Genetic control of the pathogenesis of diseases based on iron accumulation EUROIRON1participant2.796.00011
2006-11-01Integrated genomics, clinical research and care in hypertension INGENIOUS HYPERCAREparticipant10.000.00033
2006-08-01Tuning the brain for music BRAINTUNINGparticipant2.500.0006
2006-05-01The origins, representation and use of abstract concepts ABSTRACTcoordinator1.378.2005
2006-04-01International graduate program in molecular medicine INTEGRAMMcoordinator1.865.3047
2005-11-01Genome-wide analysis of signaling pathways in regulation of the interactions between tumor and host cells: applications for cancer therapy TUMOR-HOST GENOMICSparticipant2.700.0004
2005-10-01Enhancing Human Capacities: Ethics, Regulation and European Policy ENHANCEparticipant570.0005
2005-04-01Diagnostic molecular imaging DIMIparticipant10.700.00046
2004-11-01Concerted Safety & Efficiency Evaluation of Retroviral Transgenesis in Gene Therapy of Inherited Diseases CONSERTparticipant11.635.00024
2004-01-01Abnormal proteins in the pathogenesis of neurodegenerative disorders APOPISparticipant8.995.51734
2004-01-01Strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, ALL, CLL, MDS, CMPD) by integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe EUROPEAN LEUKEMIANETparticipant6.000.000177
2001-12-01Generation and functional characterization of neuroendocrine cells for cellular replacement therapy (GROWBETA) GROWBETAparticipant1.406.5096
2001-01-01The genetic control of brain development BRAIN GENESparticipant1.467.0246
2000-11-01European network to develop genetic markers for essential hypertension EURNETGENparticipant1.256.0416
2000-10-01Cell and molecular basis of cortical development (CONSORTIUM ON CORTICAL DEVELOPMENT) CONSORTIUM ON CORTICparticipant2.321.20810
2000-09-01A paradigm for the establishment of new prognostic markers for common cancers: protease systems as indicators of invasive potential. PROTEASESparticipant1.942.9797
2000-03-01Enhanced multiphoton excitation methods for neuroscience 2-PHOTON EXCITATIONparticipant1.814.0008
2000-01-01Signal transduction pathways in leukocyte transendothelial migration SILENTcoordinator2.036.6559

Alias institution names:
  • UNIVERSITA VITA SALUTE SAN RAFFAELE
  • UNIVERSITA VITASALUTE SAN RAFFAELE
  • UNIVERSITA' VITASALUTE SAN RAFFAELE'

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum
Ads: